These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7065784)

  • 1. The value of measuring percent high-density lipoprotein in assessing risk of cardiovascular disease.
    Lipinska I; Gurewich V
    Arch Intern Med; 1982 Mar; 142(3):469-72. PubMed ID: 7065784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
    Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population.
    Vekic J; Topic A; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V
    Clin Biochem; 2007 Mar; 40(5-6):310-6. PubMed ID: 17291473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular diseases in patients with high levels of plasma high density lipoprotein: association with increased plasma oxidative state.
    Shimoni N; Kaplan M; Keidar S
    Isr Med Assoc J; 2003 Oct; 5(10):702-5. PubMed ID: 14719463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
    Holcombe SM; Brubaker PH
    J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy.
    Jankowski J; Nofer JR; Tepel M; Griewel B; Schlüter H; Assmann G; Zidek W
    Clin Sci (Lond); 1998 Oct; 95(4):489-95. PubMed ID: 9748425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region.
    Barzi F; Patel A; Woodward M; Lawes CM; Ohkubo T; Gu D; Lam TH; Ueshima H;
    Ann Epidemiol; 2005 May; 15(5):405-13. PubMed ID: 15840555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
    Rothenbacher D; Brenner H; März W; Koenig W
    Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.